As the in vitro data indicated that DSF-Cu++ induces apoptosis in a wide range of Shh-driven and Group 3 lines at nanomolar concentrations, we decided to assess its anti-cancer potential and clinical applicability in well-established intracranial models of pediatric MB. This evidence concerns the gene SHH and cancer.